“Proton therapy […] seems to have decisive advantages with regard to the long-te...
In an effort to address health disparities linked to low socioeconomic environme...
In your coverage, please use this URL to provide access to the freely available ...
“Innovation X Scientific Flight” program, a new paradigm for low-cost space scie...
By Wynne Parry Credit: Michael Shribak and Kristin Gribble By Wynne Parry Much a...
Biogen announced an agreement worth an estimated $7.3 billion to acquire Reata P...
Amgen has announced successful results from a late-stage clinical trial for its ...
Aravive has encountered a significant setback as its phase 3 clinical trial for ...
Terumo Blood and Cell Technologies have introduced the Reveos system, an automat...
Everest Medicines and Calliditas recently completed patient enrollment for the C...
Mesoblast plans follows an FDA response to the BLA resubmission for remestemcel-...
Evox and the Icahn School of Medicine will develop gene delivery vectors for car...
Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently...
Cellectis provided updates for the three CAR-T cell therapies trials, with the t...
Gilead Sciences has posted net income of $1.03bn in Q2 of 2023 compared with $1....
Amid one of the worst dengue fever outbreaks in decades, Bangladesh has recorded...
